文献速递瓣膜外科主动脉外科

冰冻保存同种移植物行主动脉根部置换术治疗北美阿片类流行时代感染性心内膜炎

Aortic root replacement with cryopreserved homograft for infective endocarditis in the modern North American opioid epidemic.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-06-04

回顾性研究2011-2017年因主动脉根部脓肿行冰冻保存同种主动脉根部置换术的138例感染性心内膜炎患者,采用改良Bentall技术。手术死亡率为12.3%,估计5年死亡率为43%,结论认为该术式对高危患者是安全且可取的选择。

要点

  • 冰冻保存同种移植物行主动脉根部置换术可用于高危感染性心内膜炎伴主动脉根部脓肿患者。
  • 手术死亡率为12.3%,5年估计死亡率为43%。
  • 术后永久性卒中、透析依赖和永久起搏器植入率均为3.6%-15.2%。

核心结论

  • 冰冻保存同种移植物置换是高危感染性心内膜炎伴主动脉根部脓肿患者安全且可取的选择。
  • 同种移植物适应广泛清创后的主动脉瓣环床,为需要主动脉根部置换伴瓣环脓肿的患者提供了合理的手术策略。

研究设计与样本

  • 回顾性研究2011-2017年行冰冻保存同种主动脉根部置换术的患者。
  • 采用改良Bentall技术行主动脉根部置换术。
  • 共纳入138例因主动脉根部脓肿行冰冻保存同种移植物置换的患者。
  • 主要结局为短期和中期生存,次要结局为术后即刻并发症。

主要发现

  • 手术死亡率为12.3%(17例)。
  • 5例(3.6%)发生永久性卒中,21例(15.2%)因肾衰竭需要透析,21例(15.2%)发生完全性心脏传导阻滞需要永久起搏器。
  • 队列估计5年死亡率为43%。

临床怎么用

  • 对于感染性心内膜炎伴主动脉根部脓肿的高危患者,可考虑使用冰冻保存同种移植物行主动脉根部置换术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study mid-term survival in patients with infective endocarditis as a result of IV drug use undergoing aortic root replacement with cryopreserved aortic homograft. METHODS: Patients undergoing aortic root homograft replacement from 2011-2017 were studied retrospectively. Aortic root replacement was performed using a modified Bentall technique. Primary outcomes included both short-term and mid-term survival. Secondary outcomes included immediate postoperative complications. RESULTS: A total of 138 patients underwent cryopreserved homograft replacement of the aortic root for aortic root abscesses. Eighty-five patients (61.6%) underwent reoperative sternotomy, and 12 patients (8.7%) underwent second or third reoperative sternotomy. Sixty-seven (48.5%) patients had severe aortic insufficiency preoperatively. Operative mortality was 12.3% (17 patients). Five patients (3.6%) sustained a permanent stroke. Twenty-one patients (15.2%) required dialysis for renal failure, and 21 patients (15.2%) had complete heart block necessitating a permanent pacemaker. Estimated 5-year mortality for the cohort was 43%. CONCLUSIONS: Cryopreserved homograft replacement is a safe and desirable option for high-risk patients with infective endocarditis and aortic root abscess. Homograft accommodation for a widely debrided aortic annular bed provides a reasonable surgical strategy for patients needing aortic root replacement with annular abscess.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Sultan I, Bianco V, Kilic A, et al. Aortic root replacement with cryopreserved homograft for infective endocarditis in the modern North American opioid epidemic. J Thorac Cardiovasc Surg. 2018. PMID: 30285921. doi:10.1016/j.jtcvs.2018.05.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。